Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses
Viruses · 2024
DOI: 10.3390/v16091365 ↗Kurz gefasst
Klinische Studie (Phase I) in der Zeitschrift Viruses, 2024. Verfasst von Ying Huang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: AIDS Vaccines, HIV Infections, Immunoglobulin G, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), NIAID NIH HHS.
Abstract (Originalsprache)
Identifying correlations between immune responses elicited via HIV and non-HIV vaccines could aid the search for correlates of HIV protection and increase statistical power in HIV vaccine-efficacy trial designs. An exploratory objective of the HVTN 097 phase 1b trial was to assess whether immune responses [focusing on those supported as correlates of risk (CoR) of HIV acquisition] induced via the RV144 pox-prime HIV vaccine regimen correlated with those induced via tetanus toxoid (TT) and/or hepatitis B virus (HBV) vaccines. We measured TT-specific and HBV-specific IgG-binding antibody responses and TT-specific and HBV-specific CD4+ T-cell responses at multiple time points in HVTN 097 participants, and we assessed their correlations at peak time points with HIV vaccine (ALVAC-HIV and AIDSVAX B/E)-induced responses. Four correlations were significant [false discovery rate-adjusted p-value (FDR) ≤ 0.2]. Three of these four were with IgG-binding antibody responses to TT measured one month after TT receipt, with the strongest and most significant correlation [rho = 0.368 (95% CI: 0.096, 0.588; p = 0.008; FDR = 0.137)] being with IgG-binding antibody responses to MN gp120 gDneg (B protein boost) measured two weeks after the second ALVAC-HIV and AIDSVAX B/E boost. The fourth significant correlation [(rho = 0.361; 95% CI: 0.049, 0.609; p = 0.021; FDR = 0.137)] was between CD4+ T-cell responses to a hepatitis B surface antigen peptide pool, measured 2 weeks after the third HBV vaccination, and IgG-binding antibody responses to gp70BCaseAV1V2 (B V1V2 immune correlate), measured two weeks after the second ALVAC-HIV and AIDSVAX B/E boost. These moderate correlations imply that either vaccine, TT or HBV, could potentially provide a moderately useful immunogenicity predictor for the ALVAC-HIV and AIDSVAX B/E HIV vaccine regimen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.
- Cape Town HVTN Immunology Laboratory, Cape Town 8001, South Africa.
- Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Soweto, Johannesburg 2193, South Africa.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
ORCID-Profile: Ying Huang, Shomoita Alam, Lindsay N Carpp, Fatima Laher, Guido Ferrari, James G Kublin, Peter B Gilbert
Förderung
- NCI NIH HHS
- National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)
- NIAID NIH HHS
- National Cancer Institute of the NIH
Zitieren
APA
Huang, Y., Alam, S., Andersen-Nissen, E., Carpp, L. N., Dintwe, O. B., Flach, B. S., Grunenberg, N., Laher, F., De Rosa, S. C., Ferrari, G., Innes, C., Bekker, L. G., Kublin, J. G., McElrath, M. J., Tomaras, G. D., Gray, G. E., & Gilbert, P. B. (2024). Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses. Viruses. https://doi.org/10.3390/v16091365
Vancouver
Huang Y, Alam S, Andersen-Nissen E, Carpp LN, Dintwe OB, Flach BS, et al. Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses. Viruses. 2024. doi:10.3390/v16091365
BibTeX
@article{Huang2024,
author = {Huang, Ying and Alam, Shomoita and Andersen-Nissen, Erica and Carpp, Lindsay N and Dintwe, One B and Flach, Britta S and Grunenberg, Nicole and Laher, Fatima and De Rosa, Stephen C and Ferrari, Guido and Innes, Craig and Bekker, Linda-Gail and Kublin, James G and McElrath, M Juliana and Tomaras, Georgia D and Gray, Glenda E and Gilbert, Peter B},
title = {Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091365}
}
EUVIMED